HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Andrew R. Blight, Ph.D., Chief Scientific Officer, is the recipient of the Inaugural Purchase College Scientific Entrepreneurship Award. The award recognizes individuals for their scientific excellence, ability to integrate science with business, vision and innovation, social responsibility and providing a positive role model for future generations. Dr. Blight was selected by a panel of Purchase College science faculty in partnership with the Westchester County Association.
